COMPARISON BPC-157 vs TB-500: Research Peptide Comparison BPC-157 Both BPC-157 and TB-500 (Thymosin Beta-4 fragment) are among the most frequently studied peptides in preclinical research
Insulin resistance and type 2 diabetes mellitus are associated with ectopic fat deposition not only in the liver and heart, as is well recognized, but also in the pancreas
The injectable versus oral peptide comparison provides additional context
In addition, the mimics may be used for the treatment of "depression", by which we mean major depressive disorder (MDD) (also known as recurrent depressive disorder, clinical depression, major depression, unipolar depression, or unipolar disorder) and also depression that is characteristic of bipolar disorder, etc
There is no approved label, no pharmacy product, and the Phase 3 TRIUMPH program is still enrolling and reporting